NOVONIX Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

NOVONIX wird voraussichtlich ein Umsatzwachstum verzeichnen at 110.3% per annum.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Electronic Gewinnwachstum	18.8%
Wachstumsrate der Einnahmen	110.3%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	05 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

CHIA:NVX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	146	N/A	N/A	163	1
12/31/2025	33	N/A	N/A	-10	1
12/31/2024	10	-48	N/A	-40	1
6/30/2024	7	-47	-53	-37	N/A
3/31/2024	7	-47	-54	-37	N/A
12/31/2023	8	-46	-55	-36	N/A
6/30/2023	6	-53	-88	-41	N/A
3/31/2023	6	-54	-88	-39	N/A
12/31/2022	5	-56	-87	-38	N/A
6/30/2022	6	-52	-113	-29	N/A
3/31/2022	6	-39	-106	-22	N/A
12/31/2021	5	-26	-96	-14	N/A
9/30/2021	4	-20	-60	-10	N/A
6/30/2021	4	-13	-26	-6	N/A
3/31/2021	3	-14	-19	-5	N/A
12/31/2020	3	-18	-14	-5	N/A
9/30/2020	3	-16	-10	-4	N/A
6/30/2020	3	-13	-7	-4	N/A
3/31/2020	2	-15	-6	-3	N/A
12/31/2019	3	-20	-7	-4	N/A
9/30/2019	2	-18	-5	-3	N/A
6/30/2019	1	-18	-4	-3	N/A
3/31/2019	1	-13	-4	-3	N/A
12/31/2018	1	-8	-4	-2	N/A
9/30/2018	2	-8	-4	-3	N/A
6/30/2018	2	-8	-5	-3	N/A
3/31/2018	1	-7	N/A	-2	N/A
12/31/2017	1	-7	N/A	-2	N/A
9/30/2017	0	-6	N/A	-1	N/A
6/30/2017	0	-5	N/A	-1	N/A
3/31/2017	0	-3	N/A	-1	N/A
12/31/2016	0	-2	N/A	-1	N/A
9/30/2016	0	-1	N/A	-1	N/A
6/30/2016	0	-1	N/A	0	N/A
3/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A
9/30/2015	0	0	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von NVX über der Sparquote liegt (2.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von NVX schneller wachsen werden als der Markt Australian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von NVX in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: NVXDie Einnahmen des Unternehmens (110.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.8% pro Jahr).

Hohe Wachstumseinnahmen: NVXDie Einnahmen des Unternehmens (110.3% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von NVX in 3 Jahren voraussichtlich hoch sein wird

NOVONIX Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Forecast to breakeven in 2024

Forecast to breakeven in 2024

No longer forecast to breakeven

Recent updates

NOVONIX Limited has filed a Follow-on Equity Offering in the amount of AUD 5 million.

NOVONIX Limited to Report Q3, 2024 Results on Oct 30, 2024

Director recently sold AU$93k worth of stock

First half 2024 earnings released: US$0.059 loss per share (vs US$0.058 loss in 1H 2023)

NOVONIX Limited Announces Board Changes

NOVONIX Limited Announces Resignation of Nick Liveris as Chief Financial Officer

New minor risk - Share price stability

Axon Graphite Limited signed a definitive agreement to acquire Md South Tenements Pty. Ltd. from NOVONIX Limited (ASX:NVX) for approximately AUD 10 million on April 3, 2024.

NOVONIX Limited, Annual General Meeting, Apr 17, 2024

New major risk - Financial position

Full year 2023 earnings released: US$0.095 loss per share (vs US$0.12 loss in FY 2022)

NOVONIX Limited Appoints Sharan Burrow AC to Its Board of Directors, Effective 28 February, 2024

NOVONIX Limited to Report Q4, 2023 Results on Jan 30, 2024

Daniel Akerson Resigns from NOVONIX Limited Board of Directors

New major risk - Revenue and earnings growth

NOVONIX Limited to Report Q3, 2023 Results on Oct 26, 2023

New major risk - Share price stability

Non-Executive Chairman recently bought AU$296k worth of stock

Novonix Limited Provide an Update on Production from Its Proprietary, Continuous Induction Generation 3 Furnaces

Novonix Limited Announces the Cessation of Zhanna Golodryga as Director

Novonix Limited Announces Board Changes

First half 2023 earnings released: US$0.058 loss per share (vs US$0.064 loss in 1H 2022)

Novonix Limited's Battery Technology Solutions Division Commissions Zero-Waste Cathode Pilot Line

Non-Executive Chairman recently sold AU$356k worth of stock

Novonix Limited announced that it expects to receive AUD 45.05 million in funding from LG Energy Solution, Ltd.

Forecast to breakeven in 2024

First half 2023 earnings released: US$0.057 loss per share (vs US$0.047 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

Novonix Limited Announces Board Appointments

Forecast to breakeven in 2024

Novonix Limited, Annual General Meeting, Oct 26, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.049 loss in FY 2021)

Novonix Limited, Annual General Meeting, Oct 26, 2022

No longer forecast to breakeven

Novonix Limited Announces Board Changes

NOVONIX Limited Announces Appointment of Jean Oelwang to Board of Directors

First half 2022 earnings: EPS in line with expectations, revenues disappoint

NOVONIX Limited Announces Preliminary Results of Environmental Impact Study

Non-Executive Director Gregory Baynton has left the company

Full year 2021 earnings released: AU$0.049 loss per share (vs AU$0.15 loss in FY 2020)

Novonix Limited announced that it expects to receive $150 million in funding from Phillips 66

First half 2021 earnings released: AU$0.031 loss per share (vs AU$0.055 loss in 1H 2020)

Novonix Limited has completed a Follow-on Equity Offering in the amount of AUD 115.13 million.

Novonix Names Jeff Dahn as Chief Scientific Advisor, Effective July 1, 2021

New 90-day high: AU$1.41

Novonix Limited Appoints Nick Liveris as Chief Financial Officer

NOVONIX Limited Appoints Chris Burns as Group Chief Executive Officer

Novonix Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.15 loss per share

New 90-day high - AU$1.96

New 90-day high - AU$1.52

Novonix Limited has completed a Follow-on Equity Offering in the amount of AUD 58.281874 million.

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken